Busulfan and Fludarabine in Patients With AML and MDS

NCT00502905 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Busulfan
DRUG: Fludarabine

Sponsor

M.D. Anderson Cancer Center